Is J&J Stock A Sell As Blood-Clot Questions Plague Its Covid Vaccine?

Is J&J Stock A Sell As Blood-Clot Questions Plague Its Covid Vaccine?
ALLISON GATLIN
·7 min read

Is JNJ stock a sell as regulators in the U.S. and Europe investigate cases of blood clots potentially tied to its Covid vaccine? Johnson & Johnson stock is currently forming a flat base.